113 related articles for article (PubMed ID: 29039100)
1. Analysis of Complement Activation by Nanoparticles.
Neun BW; Ilinskaya AN; Dobrovolskaia MA
Methods Mol Biol; 2018; 1682():149-160. PubMed ID: 29039100
[TBL] [Abstract][Full Text] [Related]
2. Qualitative analysis of total complement activation by nanoparticles.
Neun BW; Dobrovolskaia MA
Methods Mol Biol; 2011; 697():237-45. PubMed ID: 21116973
[TBL] [Abstract][Full Text] [Related]
3. Detection of Intracellular Complement Activation by Nanoparticles in Human T Lymphocytes.
Ilinskaya A; Shah A; Van Dusen A; Dobrovolskaia MA
Methods Mol Biol; 2024; 2789():109-120. PubMed ID: 38506996
[TBL] [Abstract][Full Text] [Related]
4. Complement activation-related pseudoallergy: a stress reaction in blood triggered by nanomedicines and biologicals.
Szebeni J
Mol Immunol; 2014 Oct; 61(2):163-73. PubMed ID: 25124145
[TBL] [Abstract][Full Text] [Related]
5. Nanoparticle physicochemical properties determine the activation of intracellular complement.
Ilinskaya AN; Shah A; Enciso AE; Chan KC; Kaczmarczyk JA; Blonder J; Simanek EE; Dobrovolskaia MA
Nanomedicine; 2019 Apr; 17():266-275. PubMed ID: 30794962
[TBL] [Abstract][Full Text] [Related]
6. Cancer nanomedicine and the complement system activation paradigm: anaphylaxis and tumour growth.
Moghimi SM
J Control Release; 2014 Sep; 190():556-62. PubMed ID: 24746624
[TBL] [Abstract][Full Text] [Related]
7. Development and application of an enzyme-linked immunosorbent assay for the quantitation of alternative complement pathway activation in human serum.
Mayes JT; Schreiber RD; Cooper NR
J Clin Invest; 1984 Jan; 73(1):160-70. PubMed ID: 6418767
[TBL] [Abstract][Full Text] [Related]
8. Cloaking Silica Nanoparticles with Functional Protein Coatings for Reduced Complement Activation and Cellular Uptake.
Park JH; Jackman JA; Ferhan AR; Belling JN; Mokrzecka N; Weiss PS; Cho NJ
ACS Nano; 2020 Sep; 14(9):11950-11961. PubMed ID: 32845615
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the Acute Anaphylactoid Reactogenicity of Nanoparticle-Containing Medicines and Vaccines Using the Porcine CARPA Model.
Szebeni J
Methods Mol Biol; 2024; 2789():229-243. PubMed ID: 38507008
[TBL] [Abstract][Full Text] [Related]
10. A quantitative lateral flow assay to detect complement activation in blood.
Schramm EC; Staten NR; Zhang Z; Bruce SS; Kellner C; Atkinson JP; Kyttaris VC; Tsokos GC; Petri M; Sander Connolly E; Olson PK
Anal Biochem; 2015 May; 477():78-85. PubMed ID: 25660530
[TBL] [Abstract][Full Text] [Related]
11. Complement C3 cleavage and cytokines interleukin-1beta and tumor necrosis factor-alpha in otitis media with effusion.
Närkiö-Mäkelä M; Teppo AM; Meri S
Laryngoscope; 2000 Oct; 110(10 Pt 1):1745-9. PubMed ID: 11037838
[TBL] [Abstract][Full Text] [Related]
12. Combating Complement's Deleterious Effects on Nanomedicine by Conjugating Complement Regulatory Proteins to Nanoparticles.
Wang Z; Hood ED; Nong J; Ding J; Marcos-Contreras OA; Glassman PM; Rubey KM; Zaleski M; Espy CL; Gullipali D; Miwa T; Muzykantov VR; Song WC; Myerson JW; Brenner JS
Adv Mater; 2022 Feb; 34(8):e2107070. PubMed ID: 34910334
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of nanoparticle-induced hypersensitivity in pigs: complement or not complement?
Szebeni J
Drug Discov Today; 2018 Mar; 23(3):487-492. PubMed ID: 29326077
[TBL] [Abstract][Full Text] [Related]
14. A new and rapid quantitative assay for complement activation: an ELISA for C3d.
Adelsberg BR; Kerr LD; Spiera H
Diagn Immunol; 1985; 3(4):187-90. PubMed ID: 3878762
[TBL] [Abstract][Full Text] [Related]
15. Activation of complement by therapeutic liposomes and other lipid excipient-based therapeutic products: prediction and prevention.
Szebeni J; Muggia F; Gabizon A; Barenholz Y
Adv Drug Deliv Rev; 2011 Sep; 63(12):1020-30. PubMed ID: 21787819
[TBL] [Abstract][Full Text] [Related]
16. Secreted pH-regulated antigen 1 of Candida albicans blocks activation and conversion of complement C3.
Luo S; Hartmann A; Dahse HM; Skerka C; Zipfel PF
J Immunol; 2010 Aug; 185(4):2164-73. PubMed ID: 20644161
[TBL] [Abstract][Full Text] [Related]
17. Role of complement in a murine model of peanut-induced anaphylaxis.
Kodama T; Sekine H; Takahashi M; Iwaki D; Machida T; Kanno K; Ishida Y; Endo Y; Fujita T
Immunobiology; 2013 Jun; 218(6):844-50. PubMed ID: 23182714
[TBL] [Abstract][Full Text] [Related]
18. Monitoring Surface Reactions by Combined Western Blot-ELISA Analysis.
Lin Y; Irmscher S; Skerka C
Methods Mol Biol; 2019; 1834():75-83. PubMed ID: 30324437
[TBL] [Abstract][Full Text] [Related]
19. Characterization of factors influencing on-chip complement activation to optimize parallel measurement of antibody and complement proteins on antigen microarrays.
Papp K; Végh P; Hóbor R; Erdei A; Prechl J
J Immunol Methods; 2012 Jan; 375(1-2):75-83. PubMed ID: 22000977
[TBL] [Abstract][Full Text] [Related]
20. Effect of time, temperature and anticoagulants on in vitro complement activation: consequences for collection and preservation of samples to be examined for complement activation.
Mollnes TE; Garred P; Bergseth G
Clin Exp Immunol; 1988 Sep; 73(3):484-8. PubMed ID: 2463123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
